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ABSTRACT		A	new,	simple,	precise,	accurate	and	reproducible	RP-HPLC	method	for	simultaneous	estimation	of	Amitrip-tyline	and	Perphenazine	in	bulk	and	pharmaceutical	formulations	was	developed.	Separation	of	Amitripty-line	and	Perphenazine	was	successfully	achieved	on	Inertsil	ODS	(250x4.6mm)	5µm	column	in	an	isocratic	mode	utilizing	Methanol:	ACN:	Water	(50:30:20)	at	a	flow	rate	of	1.0	ml/min	and	eluents	were	monitored	at	253nm	with	a	retention	time	of	2.440	and	5.503	minutes	for	Amitriptyline	and	Perphenazine	respectively.	The	method	was	validated	and	it	was	found	to	be	linear.	The	values	of	the	correlation	coefficient	were	found	to	0.992	for	Amitriptyline	and	0.9992	for	Perphenazine	respectively.	The	LOD	for	Perphenazine	and	Ami-triptyline	were	found	to	be	and	33.8µg/ml	and	4.2	µg/ml.	The	LOQ	for	Perphenazine	and	Amitriptyline	were	found	to	be	20.88µg/ml	and	12.12µg/ml	respectively.	The	percentage	recoveries	for	Amitriptyline	and	Per-phenazine	were	 found	to	be	within	 the	 limit	 indicates	 that	 the	proposed	method	 is	highly	accurate.	The	method	was	extensively	validated	according	to	ICH	guidelines.	 	
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INTRODUCTION	
Analytical	methods	The	number	of	drugs	 introduced	 into	 the	market	 is	increasing	every	year.	These	drugs	may	be	either	new	
entities	 or	 partial	 structural	 modification	 of	 the	existing	one.	Often	a	time	lag	exists	from	the	date	of	introduction	of	a	drug	into	the	market	to	the	date	of	its	 inclusion	 in	 pharmacopoeias[1].	 This	 happens	because	 of	 the	 possible	 uncertainties	 in	 the	continuous	and	wider	usage	of	these	drugs,	reports	of	new	toxicities	(resulting	in	their	withdrawal	from	the	market),	 development	 of	 patient	 resistance	 and	introduction	 of	 better	 drugs	 by	 competitors.	 Under	these	 conditions,	 standards	 and	 analytical	procedures	 for	 these	drugs	may	not	be	available	 in	the	pharmacopoeias.	It	becomes	necessary,	therefore	to	 develop	 newer	 analytical	 methods	 for	 such	drugs[2].	
 
Figure 1: Amitriptyline	Analytical	 methods	 should	 be	 used	 within	 good	manufacturing	 practice	 (GMP)	 and	 good	 laboratory	practice	(GLP)	environments,	and	must	be	developed	using	 the	 protocols	 set	 out	 in	 the	 International	
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Conference	on	Harmonization	(ICH)	guidelines	(Q2A	and	Q2B).	[3,	4]	
 
Figure 2: Perphenazine	Method	 development	 is	 a	 continuous	 process	 that	progresses	in	parallel	with	the	evolution	of	the	drug	product.	The	goal	and	purpose	of	the	method	should	reflect	the	phase	of	drug	development.	During	early	drug	 development,	 the	 methods	 may	 focus	 on	 API	behaviour[5].	 They	 should	 be	 suitable	 to	 support	preclinical	 safety	 evaluations,	 pre-formulation	studies,	 and	 prototype	 product	 stability	 studies.	 As	drug	development	progresses,	the	analytical	methods	are	 refined	 and	 expanded,	 based	 on	 increased	 API	and	drug	product	knowledge.	The	methods	should	be	robust	 and	 uncomplicated,	 while	 still	 meeting	 the	appropriate	 regulatory	 guidelines.	 Scouting	experiments	 are	 frequently	 performed	 during	method	 development	 to	 establish	 the	 performance	limits	 of	 the	 method,	 prior	 to	 formal	 validation	experiments[6-9].	 These	 may	 include	 forced	degradation	 studies,	 which	 are	 an	 integral	 part	 of	development	of	a	stability-indicating	method.	API	is	typically	 subjected	 to	 degradation	 by	 acid,	 base,	peroxide,	 heat,	 and	 light.	 This	 allows	 for	 a	determination	 of	 the	 capability	 of	 the	 method	 to	separate	 and	 quantify	 degradation	 products,	 while	providing	 insight	 into	 the	 main	 mechanisms	 of	degradation.	Once	a	stability-indicating	method	is	in	place,	 the	 formulated	 drug	 product	 can	 then	 be	subjected	 to	 heat	 and	 light	 in	 order	 to	 evaluate	potential	 degradation	 of	 the	API	 in	 the	 presence	 of	formulation	excipients[10]	Amitriptyline	 hydrochloride[11]	 is	 a	dibenzocycloheptene-derivative	 tricyclic	antidepressant	 (TCA).	 TCAs	 are	 structurally	 similar	to	phenothiazine.	They	contain	a	tricyclic	ring	system	with	an	alkyl	amine	substituent	on	the	central	ring.	In	non-depressed	 individuals,	 amitriptyline	 does	 not	affect	mood	 or	 arousal,	 but	may	 cause	 sedation.	 In	depressed	individuals,	amitriptyline	exerts	a	positive	effect	 on	 mood.	 TCAs	 are	 potent	 inhibitors	 of	serotonin	 and	 norepinephrine	 reuptake.	 Tertiary	amine	TCAs,	 such	 as	 amitriptyline	 are	more	 potent	inhibitors	 of	 serotonin	 reuptake	 than	 secondary	amine	TCAs,	such	as	nortriptyline.		Perphenazine[12]	 is	 an	 antipsychotic	 phenothiazine	derivative	with	actions	and	uses	similar	 to	 those	of	chlorpromazine.	This	compound	belongs	to	the	class	of	 organic	 compounds	 known	 as	 phenothiazines.	
These	are	polycyclic	aromatic	compounds	containing	a	 phenothiazine	 moiety,	 which	 is	 a	 linear	 tricyclic	system	that	consists	of	a	two	benzene	rings	joined	by	a	 para-thiazine	 ring.	 It	 acts	 by	 binding	 to	 the	dopamine	 D1	 and	 dopamine	 D2	 receptors	 and	inhibits	 their	 activity.	 The	 mechanism	 of	 the	 anti-emetic	effect	is	due	predominantly	to	blockage	of	the	dopamine	 D2	 neurotransmitter	 receptors	 in	 the	chemoreceptor	 trigger	 zone	 and	 vomiting	 centre.	Perphenazine	 also	 binds	 the	 alpha	 adrenergic	receptor.	 This	 receptor's	 action	 is	 mediated	 by	association	 with	 G	 proteins	 that	 activate	 a	phosphatidylinositol-calcium	 second	 messenger	system.	
MATERIALS	AND	METHOD	
Apparatus	The	 instrument	 used	 for	 the	 study	 was	 Shimadzu	(LC20)	HPLC,		Separation	module	2695,	UV	detector	with	Spin	chrome	software	version	2.			
Reagents	and	Materials	The	 solvents	 used	 were	 Methanol,	 Acetonitrile,	Potassium	dihydrogen	ortho	phosphate,	Dipotassium	hydrogen	 phosphate,	 Tri	 Ethyl	 Amine	 and	 HPLC	Water.	
Selection	of	detection	wavelength	The	sensitivity	of	method	that	uses	UV-	Vis	detector	depends	upon	the	proper	selection	of	wavelength.	An	ideal	wavelength	is	that	gives	maximum	absorbance	and	good	response	for	both	the	drugs	to	be	detected.	Standard	 solutions	 of	 Amitriptyline	 and	Perphenazine	were	 scanned	 in	 the	 UV	 range	 (200-400nm)	 and	 the	 spectrums	 obtained	were	 overlaid	and	 the	 overlain	 spectrum	was	 recorded.	 From	 the	overlain	 spectrum,	 253	 nm	 was	 selected	 as	 the	detection	wavelength	for	the	present	study.	
Selection	of	mobile	phase	Initially	 the	 mobile	 phase	 tried	 was	 Methanol	 and	water,	 Methanol,	 Acetonitrile	 and	 water	 in	 various	proportions.	Finally,	the	mobile	phase	was	optimized	to	Methanol:	ACN:	Water	(50:30:20)	v/v	respectively.	Chromatographic	trials	for	Simultaneous	Estimation	of	Amitriptyline	and	Perphenazine	by	RP-	HPLC.	
Trial	1:	Chromatographic	conditions Mobile	phase	 :	Methanol:ACN:Water		Column		 :		Analytical(Hyperchrom)	ODS	pH		 	 :	5.0	Ratio	 	 :		50:10:40	Column		 :	Inertsil	ODS	3V	(250×4.6×	5µ)	Wavelength	 :	253	nm	Flow	rate	 :	1ml/min	
 V. Pavan Kumar et al., (2018) Int. J. Res. Pharm. Sci & Tech., 1(1), 12-21 
14   © Rubatosis Publications | International Journal of Research In Pharmaceutical Sciences and Technology 
 
Preparation	of	mixed	standard	solution	Weigh	 accurately	 10	 mg	 of	 Amitriptyline	 and	Perphenazine	 in	 100	 ml	 of	 volumetric	 flask	 and	dissolve	 in	 10ml	 of	mobile	 phase	 and	make	 up	 the	volume	 with	 mobile	 phase.	 From	 above	 stock	solution	10	µg/ml	of	Amitriptyline	and	Perphenazine	is	 prepared	 by	 diluting	 1ml	 to	 10ml	 with	 mobile	
phase.	 This	 solution	 is	 used	 for	 recording	chromatogram.	
Observation:	The	Efficiency	was	not	satisfactory	for	Perphenazine	 and	 peak	 response	 of	 Amitriptyline	was	 very	 less.	 Hence	 it	 was	 not	 taken	 for	optimization.		
 
Figure 3: Chromatogram of Amitriptyline and Perphenazine by using mobile phase 
 
Figure 4: Chromatogram of Amitriptyline and Perphenazine by using Mobile phase 
 
Figure 5: Chromatogram of Amitriptyline and Perphenazine by using mobile phase 
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Trial-	2:	Chromatographic	conditions	Mobile	phase				 :	Methanol:	ACN:	Phosphate	buffer		pH																												:		4.5	Ratio	 	 :		50:30:20	Column		 :	Inertsil	ODS	3V	(250×4.6	×5µ)	Wavelength	 :	253nm	Flow	rate	 :	1ml/min	
	
Preparation	of	mixed	standard	solution	Weigh	 accurately	 10	 mg	 of	 Amitriptyline	 and	Perphenazine	 in	 100	 ml	 of	 volumetric	 flask	 and	dissolve	 in	 10ml	 of	mobile	 phase	 and	make	 up	 the	volume	 with	 mobile	 phase.	 From	 above	 stock	solution	10	µg/ml	of	Amitriptyline	and	Perphenazine	is	 prepared	 by	 diluting	 1ml	 to	 10ml	 with	 mobile	phase.	 This	 solution	 is	 used	 for	 recording	chromatogram.	
 
Figure 6: Chromatogram of Amitriptyline and Perphenazine by using mobile phase 
 
Figure 7: Chromatogram of Amitriptyline and Perphenazine by using mobile phase 
 
Figure 8: Chromatogram of Blank 
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Observation:	Efficiency	of	both	the	drugs	was	good.	The	run	time	is	very	more.	The	peaks	of	Amitriptyline	and	Perphenazine	 showed	 tailing.	Hence	 it	was	not	taken	for	optimization.	
Trial-	3:	Chromatographic	conditions	Mobile	phase				 :Phosphate	buffer	:	ACN	:	Methanol		pH																								 :		4.0	Ratio	 	 :		30:30:40	Column		 :		Inertsil	ODS	3V,	(250×4.6×	5µ)	Wavelength										:	253nm	Flow	rate	 :		1ml/min	
Preparation	of	mixed	standard	solution	Weigh	 accurately	 10	 mg	 of	 Amitriptyline	 and	Perphenazine	 in	 100	 ml	 of	 volumetric	 flask	 and	dissolve	 in	 10ml	 of	mobile	 phase	 and	make	 up	 the	volume	 with	 mobile	 phase.	 From	 above	 stock	solution	10	µg/ml	of	Amitriptyline	and	Perphenazine	is	 prepared	 by	 diluting	 1ml	 to	 10ml	 with	 mobile	phase.	 This	 solution	 is	 used	 for	 recording	chromatogram.	
Observation:	 Asymmetry	 factor	 for	 Perphenazine	does	not	meet	the	system	suitability	requirements.		
 
Figure 9: Chromatogram of Sample 
 
Figure 10: Calibration graph of Amitriptyline 
 
Figure 11: Calibration graph of Perphenazine     
Table 1: Calibration data of Perphenazine 
S.No. Conc (µg/ml ) Area 
1 30 347.912 
2 45 520.885 
3 60 657.488 
4 75 780.529 
5 90 892.314 
Table 2: Calibration data of Amitriptyline 
S.No. Conc (µg/ml ) Area 
1 160 3236.788 
2 240 4409.861 
3 320 5560.106 
4 400 6560.326 
5 480 7303.508 
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Table 3: Showing accuracy results for Accuracy amitriptyline 
Recovery 
level 
Accuracy amitriptyline Average % 
Recovery Amount taken (µg/ml) Area 
Average 
area 
Amount recovered 
(mcg/ml) 
%Re-
covery 
80% 
240 4662.113 
4671.027 254.21 99.30 
 
 
 
 
100.023 
 
240 4682.749 
240 4668.220 
100% 
320 5595.271 
5589.477 
 321.69 100.53 320 5588.966 
320 5584.193 
120% 
400 6296.468 6313.257 
 384.94 100.24 400 6324.060 
400 6319.242 
 
Table 4: Showing accuracy results for Perphenazine 
Recovery 
level 
Accuracy  perphenazine Average % 
Recovery Amount taken ( µg/ml) Area 
Average 
area 
Amount recovered 
(mcg/ml) 
% Re-
covery 
80% 
45 558.057 
560.812 
 48.45 100.94 
 
 
 
100.61 
45 563.349 
45 561.030 
100% 
60 657.465 
657.722 
 60.02 100.04 
60 659.972 
60 655.729 
120% 
75 751.964 755.928 
 72.64 100.88 75 755.857 75 759.963 
Table 5: Result of Robustness study 
 
Parameter 
Amitriptyline Perphenazine 
Retention time (min) Tailing factor Retention time (min) Tailing factor 
Fl
ow
 R
at
e  
0.8 ml/min 
1.0ml/min 
1.2 ml/min 
 
3.033 
2.447 
2.053 
 
1.784 
1.710 
1.704 
 
6.830 
5.513 
4.607 
 
1.583 
1.540 
1.558 
W
av
e-
le
ng
th
 240nm 
258nm 
253nm 
 
2.450 
2.443 
2.447 
 
1.742 
1.656 
1.710 
 
5.507 
5.510 
5.500 
 
1.571 
1.600 
1.540 
Table 6: Results for method precision of amitriptyline and perphenazine 
 Amitriptyline Perpheranzine 
S.No. Rt Area Rt Area 
1 2.487 4181.754 5.567 1759.963 
2 2.450 4143.434 5.533 1782.254 
3 2.477 4162.886 5.560 1776.727 
4 2.493 4199.596 5.590 1773.634 
5 2.493 4161.196 5.603 1762.717 
6 2.460 4190.188 5.570 1756.825 
Avg 2.476667 4173.176 5.5705 1768.687 
Stdev 0.018052 20.95232 0.024354 10.25314 
% RSD 0.728874 0.502071 0.43719 0.579703 
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The	run	time	is	8	minutes	and	hence	it	was	not	taken	for	optimization.	
Trial-	4:	Chromatographic	conditions	Mobile	 phase:	 	Mixed	 phosphate	 buffer:	Methanol	 :	ACN	pH	 	 :		4.5	Ratio	 	 :		30:50:20	Column		 :		Inertsil	ODS	(250×4.6×	5µ)	Wavelength										:	253	nm	Flow	rate	 :		1ml/min	
Preparation	of	mixed	standard	solution	Weigh	 accurately	 10	 mg	 of	 Amitriptyline	 and	Perphenazine	 in	 100	 ml	 of	 volumetric	 flask	 and	dissolve	 in	 10ml	 of	mobile	 phase	 and	make	 up	 the	volume	 with	 mobile	 phase.	 From	 above	 stock	solution	10	µg/ml	of	Amitriptyline	and	Perphenazine	is	 prepared	 by	 diluting	 1ml	 to	 10ml	 with	 mobile	phase.	 This	 solution	 is	 used	 for	 recording	chromatogram.		
Observation:	 Peak	 Asymmetry	 factor	 for	Amitriptyline	 and	 Perphenazine	 does	 not	meet	 the	system	suitability	requirements.	The	run	time	is	very	more	hence	it	was	not	taken	for	optimization.	
Trial-	5:	Chromatographic	conditions	(Optimized	
Method)	Mobile	phase							:		METHANOL:	ACN:	WATER		Ratio	 	 :			50:30:20	Column		 :			Inertsil	ODS	(250×4.6×	5µ)	Wavelength										:		253	nm	Flow	rate	 :		1ml/min	
Preparation	of	mixed	standard	solution	Weigh	 accurately	 10	 mg	 of	 Amitriptyline	 and	Perphenazine	 in	 100	 ml	 of	 volumetric	 flask	 and	dissolve	 in	 10ml	 of	mobile	 phase	 and	make	 up	 the	volume	 with	 mobile	 phase.	 From	 above	 stock	solution	10	µg/ml	of	Amitriptyline	and	Perphenazine	is	 prepared	 by	 diluting	 1ml	 to	 10ml	 with	 mobile	
phase.	 This	 solution	 is	 used	 for	 recording	chromatogram.	
Observation:	All	the	system	suitability	requirements	were	met.	The	peak	Asymmetry	factor	was	less	than	2	 for	 both	 Amitriptyline	 and	 Perphenazine.	 The	efficiency	was	more	than	2000	for	both	Amitriptyline	and	 Perphenazine	 Resolution	 between	 two	 peaks	>1.5.	Hence	this	method	was	for	optimized.		
Procedure	
Preparation	of	mixed	standard	solution	weigh	 accurately	 10	 mg	 of	 Amitriptyline	 and	Perphenazine	 	 in	 100	 ml	 of	 volumetric	 flask	 and	dissolve	 in	 10ml	 of	mobile	 phase	 and	make	 up	 the	volume	 with	 mobile	 phase.	 From	 above	 stock	solution	10	µg/ml	of	Amitriptyline	and	Perphenazine	is	 prepared	 by	 diluting	 1ml	 to	 10ml	 with	 mobile	phase.	 This	 solution	 is	 used	 for	 recording	chromatogram.		
Tablet	sample	10	tablets	(each	tablet	contains	Amitriptyline	150	mg	and	Perphenazine	8	mg)	were	weighed	and	 	 	 taken	into	 a	 mortar	 and	 crushed	 to	 fine	 powder	 and	uniformly	 mixed.	 Tablet	 stock	 solutions	 of	Amitriptyline	 and	 Perphenazine	 (μg/ml)	 were	prepared	by	dissolving	weight	equivalent	to	8	mg	of	Perphenazine	 and	 150	 mg	 of	 Amitriptyline	 and	dissolved	 in	 sufficient	 mobile	 phase.	 After	 that	filtered	the	solution	using	0.45-micron	syringe	filter	and	 Sonicated	 for	 5	 min	 and	 dilute	 to	 50ml	 with	mobile	 phase.	 Further	 dilutions	 are	 prepared	 in	 5	replicates	 of	 10	 μg/ml	 of	 Amitriptyline	 and	Perphenazine	 was	 made	 by	 adding	 1	 ml	 of	 stock	solution	to	10	ml	of	mobile	phase.	
Assay	
Preparation	 of	 samples	 for	 Assay:	 Standard	
solution	Weigh	accurately	8	mg	of	Amitriptyline	and	1.5	mg	of	Perphenazine	 in	 25	 ml	 of	 volumetric	 flask	 and	
Table 7: Results for Ruggedness 
Amitriptyline %Assay Perpheranzine %Assay 
Analyst 01 100% Analyst 01 100% 
Anaylst 02 99.54% Anaylst  02 99.93% 
Table 8: LOD 
Drug name LOD(µg) 
Amitriptyline 33.8 
Perphenazine 4.2 
Table 9: LOQ 
Drug name LOQ(µg) 
Amitriptyline 20.88 
Perphenazine 12.12 
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dissolve	 in	 10ml	 of	mobile	 phase	 and	make	 up	 the	volume	 with	 mobile	 phase.	 This	 solution	 contains	320	 µg/ml	 of	 Amitriptyline	 and	 60	 µg/ml	 of	Perphenazine.	 This	 solution	 is	 used	 for	 recording	chromatogram.	
Tablet	sample	10	tablets	(each	tablet	contains	Amitriptyline	150	mg	and	 Perphenazine	 8	 mg)	 were	 weighed	 and	 taken	into	 a	 mortar	 and	 crushed	 to	 fine	 powder	 and	uniformly	 mixed.	 Tablet	 stock	 solution	 of	Amitriptyline	 and	 Perphenazine	 (μg/ml)	 was	prepared	by	dissolving	weight	equivalent	to	800	mg	of	 Amitriptyline	 and	 150mg	 of	 Perphenazine	dissolved	 in	 sufficient	 mobile	 phase.	 After	 that	filtered	the	solution	using	0.45-micron	syringe	filter	and	 Sonicated	 for	 5	 min	 and	 dilute	 to	 25	 ml	 with	mobile	 phase.	 This	 solution	 contains	 320	 µg/ml	 of	Amitriptyline	 and	 60	 µg/ml	 of	 Perphenazine.	 This	solution	is	used	for	recording	chromatogram.	
Calculation	The	 amount	 of	 Amitriptyline	 and	 Perphenazine	present	in	the	formulation	by	using	the	formula	given	below,	and	results	shown	in	table.	Where,	AS:		Average	peak	area	due	to	standard	preparation	AT:		Peak	area	due	to	assay	preparation	WS:	Weight	of	Amitriptyline/Perphenazine	in	mg	WT:	Weight	of	sample	in	assay	preparation	DT:	Dilution	of	assay	preparation	
RESULTS	AND	DISCUSSION	
Method	Validation	Parameters	
Specificity		The	system	suitability	for	specificity	was	carried	out	to	determine	whether	there	is	any	interference	of	any	impurities	 in	retention	time	of	analytical	peak.	 	The	specificity	was	performed	by	
Linearity	The	linearity	of	an	analytical	method	is	its	ability	to	elicit	test	results	that	are	directly,	or	by	a	well-defined	mathematical	 transformation,	 proportional	 to	 the	concentration	 of	 analyte	 in	 samples	within	 a	 given	range.	Weigh	accurately	16mg	of	Amitriptyline	and	3	mg	of	Perphenazine	in	50	ml	of	volumetric	flask	and	dissolve	 in	 10ml	 of	mobile	 phase	 and	make	 up	 the	volume	 with	 mobile	 phase.	 This	 solution	 contains	160-480	µg/ml	of	Amitriptyline	and	30-90	µg/ml	of	Perphenazine	 Acceptance	 criteria:	 Correlation	coefficient	should	be	not	less	than	0.999.	
Range	
Based	on	precision,	linearity	and	accuracy	data	it	can	be	concluded	that	the	assay	method	is	precise,	linear	and	accurate	in	the	range	of	160-480	ppm	and	30-90	ppm	 for	 Amitriptyline	 and	 Perphenazine		respectively	
Accuracy	Accuracy	of	the	method	was	determined	by	recovery	experiments.	 There	 are	 mainly	 2types	 of	 recovery	studies	are	there.	
Standard	addition	method:	To	the	formulation,	the	reference	standard	of	 the	respective	drug	of	known	concentration	 was	 added,	 analyzed	 by	 HPLC	 and	compared	with	the	standard	drug	concentration.		
Percentage	 method:	 For	 these	 assay	 method	samples	 are	 prepared	 in	 three	 concentrations	 of			80%,	100%,	and	120%	respectively.	
Acceptance	 criteria:	The	mean	%	 recovery	 of	 the	Amitriptyline	and	Perphenazine	at	each	level	should	be	not	less	than	95.0%	and	not	more	than	105.0%.	
Assay	procedure	10mL	 of	 the	 standard	 and	 sample	 solutions	 of	Amitriptyline	 and	 Perphenazine	 were	 injected	 into	the	 HPLC	 system	 and	 the	 chromatograms	 were	recorded.	Amount	of	drug	present	in	the	Tablets	were	calculated	using	the	peak	areas.		
Precision		Method	precision	also	 called	as	 repeatability/Intra-day	 precision	 indicates	 whether	 a	 method	 gives	consistent	results	for	a	single	batch.	Method	precision	was	demonstrated	by	preparing	six	test	solutions	at	100%	 concentration	 as	 per	 the	 test	 procedure	 &	recording	the	chromatograms	of	six	test	solutions.		The	 %	 RSD	 of	 peak	 areas	 of	 six	 samples	 was	calculated.	The	method	precision	was	performed	on	Amitriptyline	and	Perphenazine	formulation.	
Acceptance	criteria	The	%	RSD	for	the	area	of	sample	injections	results	should	not	be	more	than	2.	
Selection	of	solvent	Solutions	 of	 Amitriptyline	 and	 Perphenazine	 were	prepared	 by	 dissolving	 in	 mobile	 phase	 and	 UV	spectrum	of	each	was	recorded	by	scanning	between	200-400	nm.	
VALIDATION	OF	THE	METHOD	
LINEARITY	Amitriptyline	 and	 Perphenazine:	 Serial	 dilutions	 of	Amitriptyline	and	Perphenazine	 (160-480	ppm	and	
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30-90	 ppm)	 were	 injected	 into	 the	 column	 and	detected	 at	 a	 wavelength	 set	 at	 253	 nm.	 The	calibration	 curve	 was	 obtained	 by	 plotting	 the	concentration	 vs.	 peak	 area	 and	 the	 correlation	coefficient	 was	 found	 to	 be	 0.992	 and	 0.992	respectively.	
SUMMARY	AND	CONCLUSION	A	 new	 method	 was	 established	 for	 simultaneous	estimation	of	Amitriptyline	and	Perphenazine	by	RP-HPLC	method.	The	chromatographic	conditions	were	successfully	 developed	 for	 the	 separation	 of	Amitriptyline	and	Perphenazine	by	using	C18	column	(4.6×250mm)	 5µ,	 flow	 rate	 was	 1ml/min,	 mobile	phase	 ratio	 was	 (50:30:20	 v/v)	 Methanol:	 ACN:	Water,	detection	wavelength	was	253	nm.	Precision	and	recovery	studies	were	also	found	to	be	with	the	range.	The	proposed	HPLC	method	was	found	to	be	simple,	 specific,	 precise,	 accurate,	 rapid	 and	economical	 for	 simultaneous	 estimation	 of	Amitriptyline	 and	 Perphenazine	 in	 pharmaceutical	dosage	form.	The	developed	method	was	validated	in	terms	 of	 accuracy,	 precision,	 linearity,	 robustness	and	 ruggedness,	 and	 results	 will	 be	 validated	statistically	according	to	ICH	guidelines.	The	Sample	recoveries	 in	 all	 formulations	 were	 in	 good	agreement	with	their	respective	label	claims.	Hence	 the	 suggested	RP-HPLC	method	 can	 be	 used	for	 routine	 analysis	 of	 Amitriptyline	 and	Perphenazine	in	API	and	Pharmaceutical	dosage	form	
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